Construction, Characterization and Preclinical Evaluation of MTBVAC, the First Live-Attenuated M. Tuberculosis-Based Vaccine to Enter Clinical Trials
Vaccine - Netherlands
doi 10.1016/j.vaccine.2013.07.051
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2013
Authors
Publisher
Elsevier BV